UNC Lineberger Comprehensive Cancer Center

03/06/2026

Yara Abdou, MD, was selected for Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award. She leads the breast cancer clinical trial program at UNC Lineberger.

Congratulations, Dr. Abdou 👏 https://news.unchealthcare.org/2026/03/unc-school-of-medicine-oncologist-named-recipient-of-winn-clinical-investigator-leadership-award/

03/05/2026

UNC Lineberger's Deborah Stephens, DO, a hematologist and oncologist with UNC Health who specializes in the treatment of chronic lymphocytic leukemia (CLL), shares diagnosis and treatment information about this slow-growing blood cancer.

You may have this blood cancer and not require treatment.

03/05/2026

Sign up today! https://impact.headforthecure.org/event/head-for-the-cure-5k-nc-triangle-2026/e730454

Only four days left before the Triangle Head For The Cure 5K! Support brain cancer research at UNC Lineberger Comprehensive Cancer Center and register today!

03/04/2026

Save the date to join us May 4-5 in Chapel Hill for the 49th Annual UNC Lineberger Scientific Symposium! This year's event features presentations on innovative directions in RNA biology and therapeutics.

03/03/2026

UNC Lineberger researchers Jessica Stewart, PhD and Blossom Damania, PhD offered a new and promising solution for EBV-positive cancer in their recent study published in Blood.

New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.

03/02/2026

This Multiple Myeloma Awareness Month, we recognize the resilience of those facing this cancer and the teams working to advance treatment.

UNC Lineberger is recruiting for a clinical study evaluating a lower‑dose treatment approach for people newly diagnosed with multiple myeloma.

The research aims to achieve a better response while causing fewer or less severe side effects for patients.

The purpose of this study is to evaluate the safety and effectiveness of isatuximab when used in combination with lenalidomide and dexamethasone at lower doses. This study will test lower doses of these drugs to reduce the likelihood of any harmful side effects that may be experienced. The study tea...

02/27/2026

The first UNC Lineberger Endometrial Cancer Center of Excellence retreat brought together physicians, trainees and patient advocates to discuss advancing research and clinical care for endometrial cancer.

Included was the announcement of a five-year, $11.2 million Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute!
https://unclineberger.org/news/inaugural-endometrial-cancer-center-of-excellence-retreat-strengthens-fight-against-endometrial-cancer/

02/26/2026

A single sample. Clearer insights. In a collaboration between several labs at UNC Lineberger, Laura Peng, PhD, Ian McCabe and Elena Kharitonova have developed a new way to analyze one patient sample and identify key cell types around a tumor.

This information could help guide more personalized cancer treatment.

Published in Cell Reports Medicine, researchers have defined cancer-associated fibroblast (CAF) subtypes that are clinically robust, prognostic, and predictive of immunotherapy response.

02/25/2026

UNC Lineberger's Linda Van Le, MD shares the warning signs of ovarian cancer. The lack of screening and vague symptoms mean ovarian cancer is typically not found until it’s in an advanced stage.

This reproductive cancer is difficult to catch early.

02/24/2026

Study findings from UNC Lineberger's Marissa Hall, PhD, and colleagues suggest the current US alcohol warning label may no longer be an effective tool for communicating alcohol-related health risks to consumers.

“This study suggests that the current alcohol warning label leaves a lot to be desired when it comes to capturing people’s attention," Hall explained.

February 12, 2026 Only about one in four adult alcohol consumers in the United States has read the federal alcohol health warning in the past month — and even fewer remember what it says, according to new research led by Dr. Marissa Hall.

02/23/2026

UNC Lineberger has launched a resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers across the state!

“Compiling these data and putting it all in one place will make information searching, research idea generation, and monitoring public health actions more convenient,” said UNC Lineberger's Lisa Spees, PhD.

The tool is a one-stop resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs throughout the state.

02/23/2026

”Fortunately, with new technology, a lot that we are employing here at UNC, we are able to diagnose patients at a much earlier stage and at a point where they can be cured.” 🩵